Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR
- 1 July 2007
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 56 (7) , 964-970
- https://doi.org/10.1099/jmm.0.47149-0
Abstract
In view of both the delay in obtaining identification by conventional methods following blood-culture positivity in patients with candidaemia and the close relationship between species and fluconazole (FLC) susceptibility, early speciation of positive blood cultures has the potential to influence therapeutic decisions. The aim was to develop a rapid test to differentiate FLC-resistant from FLC-sensitive Candida species. Three TaqMan-based real-time PCR assays were developed to identify up to six Candida species directly from BacT/Alert blood-culture bottles that showed yeast cells on Gram staining at the time of initial positivity. Target sequences in the rRNA gene complex were amplified, using a consensus two-step PCR protocol, to identify Candida albicans, Candida parapsilosis, Candida tropicalis, Candida dubliniensis, Candida glabrata and Candida krusei; these are the most commonly encountered Candida species in blood cultures. The first four of these (the characteristically FLC-sensitive group) were identified in a single reaction tube using one fluorescent TaqMan probe targeting 18S rRNA sequences conserved in the four species. The FLC-resistant species C. krusei and C. glabrata were detected in two further reactions, each with species-specific probes. This method was validated with clinical specimens (blood cultures) positive for yeast (n=33 sets) and the results were 100 % concordant with those of phenotypic identification carried out concomitantly. The reported assay significantly reduces the time required to identify the presence of C. glabrata and C. krusei in comparison with a conventional phenotypic method, from ∼72 to <3 h, and consequently allows optimization of the antifungal regimen at an earlier stage.Keywords
This publication has 36 references indexed in Scilit:
- Peptide Nucleic Acid Fluorescence In Situ Hybridization-Based Identification of Candida albicans and Its Impact on Mortality and Antifungal Therapy CostsJournal of Clinical Microbiology, 2006
- Candidaemia in a large teaching hospital: a clinical auditQJM: An International Journal of Medicine, 2006
- Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCRClinical Microbiology & Infection, 2006
- Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional StudyClinical Infectious Diseases, 2006
- Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood culturesDiagnostic Microbiology and Infectious Disease, 2006
- DNA probes for the rapid identification of medically importantCandidaspecies using a multianalyte profiling systemFEMS Immunology & Medical Microbiology, 2006
- Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Multicenter Evaluation of a Candida albicans Peptide Nucleic Acid Fluorescent In Situ Hybridization Probe for Characterization of Yeast Isolates from Blood CulturesJournal of Clinical Microbiology, 2005
- Detection of seven Candida species using the Light-Cycler systemJournal of Medical Microbiology, 2003
- Differentiation of Candida albicans and Candida dubliniensis by Fluorescent In Situ Hybridization with Peptide Nucleic Acid ProbesJournal of Clinical Microbiology, 2001